Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole

Pediatrics. 2019 Jun;143(6):e20183242. doi: 10.1542/peds.2018-3242.

Abstract

Pulmonary toxicity induced by trimethoprim-sulfamethoxazole (TMP-SMX) has been described, although the disease process is poorly understood. We report 5 previously healthy adolescent patients who developed acute respiratory failure while taking TMP-SMX. Four of the 5 adolescents required extracorporeal membrane oxygenation support, and 2 of the teenagers died. All children required a tracheostomy, and all cases were complicated by pneumothoraces and pneumomediastinum. The majority of children were prescribed TMP-SMX for the treatment of acne vulgaris.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adolescent
  • Anti-Bacterial Agents / adverse effects*
  • Female
  • Humans
  • Male
  • Respiratory Insufficiency / chemically induced*
  • Respiratory Insufficiency / diagnostic imaging*
  • Severity of Illness Index*
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects*

Substances

  • Anti-Bacterial Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination